Logo image of CXI.CA

CURRENCY EXCHANGE INTERNATIO (CXI.CA) Stock Fundamental Analysis

TSX:CXI - Toronto Stock Exchange - US23131B3078 - Common Stock - Currency: CAD

21.21  -0.28 (-1.3%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CXI. CXI was compared to 7 industry peers in the Consumer Finance industry. While CXI has a great health rating, there are worries on its profitability. CXI scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CXI was profitable.
In the past year CXI had a positive cash flow from operations.
In multiple years CXI reported negative net income over the last 5 years.
In multiple years CXI reported negative operating cash flow during the last 5 years.
CXI.CA Yearly Net Income VS EBIT VS OCF VS FCFCXI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

The Return On Assets of CXI (1.89%) is comparable to the rest of the industry.
CXI has a Return On Equity (3.12%) which is in line with its industry peers.
CXI's Return On Invested Capital of 6.85% is fine compared to the rest of the industry. CXI outperforms 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CXI is below the industry average of 11.04%.
Industry RankSector Rank
ROA 1.89%
ROE 3.12%
ROIC 6.85%
ROA(3y)6.33%
ROA(5y)1.59%
ROE(3y)10.99%
ROE(5y)3.28%
ROIC(3y)8.03%
ROIC(5y)N/A
CXI.CA Yearly ROA, ROE, ROICCXI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CXI has a Profit Margin (2.90%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CXI has declined.
The Operating Margin of CXI (14.89%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CXI has grown nicely.
Industry RankSector Rank
OM 14.89%
PM (TTM) 2.9%
GM N/A
OM growth 3YN/A
OM growth 5Y5.24%
PM growth 3YN/A
PM growth 5Y-16.12%
GM growth 3YN/A
GM growth 5YN/A
CXI.CA Yearly Profit, Operating, Gross MarginsCXI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

10

2. Health

2.1 Basic Checks

CXI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CXI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CXI has less shares outstanding
CXI has a better debt/assets ratio than last year.
CXI.CA Yearly Shares OutstandingCXI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CXI.CA Yearly Total Debt VS Total AssetsCXI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.25 indicates that CXI is not in any danger for bankruptcy at the moment.
The Altman-Z score of CXI (3.25) is better than 100.00% of its industry peers.
CXI has a debt to FCF ratio of 0.48. This is a very positive value and a sign of high solvency as it would only need 0.48 years to pay back of all of its debts.
The Debt to FCF ratio of CXI (0.48) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CXI is not too dependend on debt financing.
CXI has a better Debt to Equity ratio (0.13) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.48
Altman-Z 3.25
ROIC/WACC0.88
WACC7.82%
CXI.CA Yearly LT Debt VS Equity VS FCFCXI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CXI has a Current Ratio of 2.65. This indicates that CXI is financially healthy and has no problem in meeting its short term obligations.
CXI has a better Current ratio (2.65) than 100.00% of its industry peers.
CXI has a Quick Ratio of 2.65. This indicates that CXI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.65, CXI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.65
CXI.CA Yearly Current Assets VS Current LiabilitesCXI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

CXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.01%.
CXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.90% yearly.
The Revenue has been growing slightly by 3.83% in the past year.
CXI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.33% yearly.
EPS 1Y (TTM)-78.01%
EPS 3YN/A
EPS 5Y-3.9%
EPS Q2Q%23.53%
Revenue 1Y (TTM)3.83%
Revenue growth 3Y40.76%
Revenue growth 5Y15.33%
Sales Q2Q%1.15%

3.2 Future

CXI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.26% yearly.
CXI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y65.57%
EPS Next 2Y35.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.66%
Revenue Next 2Y3.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CXI.CA Yearly Revenue VS EstimatesCXI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
CXI.CA Yearly EPS VS EstimatesCXI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.12, CXI is valued correctly.
CXI's Price/Earnings ratio is a bit cheaper when compared to the industry. CXI is cheaper than 71.43% of the companies in the same industry.
CXI is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.32, which indicates a rather cheap valuation of CXI.
CXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. CXI is cheaper than 85.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CXI to the average of the S&P500 Index (22.10), we can say CXI is valued rather cheaply.
Industry RankSector Rank
PE 12.12
Fwd PE 7.32
CXI.CA Price Earnings VS Forward Price EarningsCXI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CXI is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.93
EV/EBITDA -0.15
CXI.CA Per share dataCXI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CXI's earnings are expected to grow with 35.26% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y35.26%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXI!.
Industry RankSector Rank
Dividend Yield N/A

CURRENCY EXCHANGE INTERNATIO

TSX:CXI (3/7/2025, 7:00:00 PM)

21.21

-0.28 (-1.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)01-22 2025-01-22/amc
Earnings (Next)03-11 2025-03-11
Inst Owners8.21%
Inst Owner ChangeN/A
Ins Owners25.95%
Ins Owner ChangeN/A
Market Cap133.41M
Analysts80
Price Target30.6 (44.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.42%
Min EPS beat(2)-36.02%
Max EPS beat(2)-12.81%
EPS beat(4)0
Avg EPS beat(4)-42.76%
Min EPS beat(4)-71.71%
Max EPS beat(4)-12.81%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.77%
Min Revenue beat(2)-5.7%
Max Revenue beat(2)-1.84%
Revenue beat(4)0
Avg Revenue beat(4)-3.02%
Min Revenue beat(4)-5.7%
Max Revenue beat(4)-1.84%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.41%
EPS NY rev (3m)-7.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.48%
Revenue NY rev (3m)-3.48%
Valuation
Industry RankSector Rank
PE 12.12
Fwd PE 7.32
P/S 1.09
P/FCF 3.93
P/OCF 3.49
P/B 1.17
P/tB 1.22
EV/EBITDA -0.15
EPS(TTM)1.75
EY8.25%
EPS(NY)2.9
Fwd EY13.65%
FCF(TTM)5.39
FCFY25.43%
OCF(TTM)6.08
OCFY28.66%
SpS19.43
BVpS18.1
TBVpS17.31
PEG (NY)0.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.89%
ROE 3.12%
ROCE 14.68%
ROIC 6.85%
ROICexc N/A
ROICexgc N/A
OM 14.89%
PM (TTM) 2.9%
GM N/A
FCFM 27.76%
ROA(3y)6.33%
ROA(5y)1.59%
ROE(3y)10.99%
ROE(5y)3.28%
ROIC(3y)8.03%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.98%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y5.24%
PM growth 3YN/A
PM growth 5Y-16.12%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.48
Debt/EBITDA 0.61
Cap/Depr 79.65%
Cap/Sales 3.52%
Interest Coverage 91.21
Cash Conversion 161.96%
Profit Quality 956.64%
Current Ratio 2.65
Quick Ratio 2.65
Altman-Z 3.25
F-Score6
WACC7.82%
ROIC/WACC0.88
Cap/Depr(3y)48.53%
Cap/Depr(5y)34.74%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.01%
EPS 3YN/A
EPS 5Y-3.9%
EPS Q2Q%23.53%
EPS Next Y65.57%
EPS Next 2Y35.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.83%
Revenue growth 3Y40.76%
Revenue growth 5Y15.33%
Sales Q2Q%1.15%
Revenue Next Year2.66%
Revenue Next 2Y3.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.14%
EBIT growth 3YN/A
EBIT growth 5Y21.37%
EBIT Next Year36.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1077.3%
FCF growth 3Y45.9%
FCF growth 5Y20.75%
OCF growth 1Y2456.79%
OCF growth 3Y49.32%
OCF growth 5Y19.49%